Board of Directors

Members of our Board of Directors include:

Peter Barrett, Chair

Senior Partner in the Life Sciences sector, Atlas Ventures
Former co-founder and Executive Vice President, Celera Genomics

Alan Crane, Vice Chair

Founder and Chief Executive Officer, Cerulean Pharaceuticals
Former CEO, Momenta Pharmaceuticals
Former Senior Vice President, Corporate Development, Millennium Pharmaceuticals

Janet Atkins, Treasurer

Principal of Ridgeway Advisors

John Graham, Secretary

Partner, Sullivan Worcester

Paul Marcus

President, Davis Marcus Partners

Edward Scolnick, MD

Director, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Former President of Merck Research Laboratories 

James F. Gusella*, PhD

Senior Science Advisor, Autism Consortium
Chair, Steering Committee, Autism Consortium
Director, Center for Human Genetic Research, Massachusetts General Hospital

Deirdre B. Phillips*

Cheif Strategy Officer, Autism Consortium  

Mriganka Sur*, PhD

Department Chair of Brain and Cognitive Sciences, Massachusetts Institute of Technology 

Tish Tanski*, MSW

Executive Director, Autism Consortium

Christopher Walsh*, MD, PhD

Chair, Scientific Advisory Board, Autism Consortium
Chief, Division of Genetics, Children’s Hospital

 

* Indicates Non-Voting Member